Weiss Multi-Strategy Advisers’s NEVRO CORP. NVRO Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-15,000	Closed	-$938K	–	657
2019 Q1	$938K	Buy	+15,000	New	+$705K	0.02%	401
2018 Q3	–	Sell	-25,000	Closed	-$2M	–	675
2018 Q2	$2M	Sell	25,000 -17,500	-41%	-$1.45M	0.05%	345
2018 Q1	$3.68M	Sell	42,500 -5,500	-11%	-$444K	0.12%	228
2017 Q4	$3.31M	Buy	48,000 +3,000	+7%	+$240K	0.09%	258
2017 Q3	$4.09M	Buy	45,000 +7,000	+18%	+$599K	0.15%	194
2017 Q2	$2.83M	Buy	38,000 +18,000	+90%	+$1.44M	0.12%	237
2017 Q1	$1.87M	Buy	20,000 +9,000	+82%	+$815K	0.07%	299
2016 Q4	$799K	Buy	11,000 +5,000	+83%	+$428K	0.04%	293
2016 Q3	$626K	Sell	6,000 -8,580	-59%	-$775K	0.04%	329
2016 Q2	$1.07M	Sell	14,580 -14,420	-50%	-$979K	0.08%	258
2016 Q1	$1.63M	Buy	29,000 +24,000	+480%	+$1.42M	0.07%	287
2015 Q4	$338K	Buy	+5,000	New	+$268K	0.02%	323

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Weiss Multi-Strategy Advisers's NVRO Position: Q2 2019 in Review

Weiss Multi-Strategy Advisers sold out of NEVRO CORP. (NVRO) in Q2 2019, closing a stake of 15,000 shares — an estimated $938K sold.

Weiss Multi-Strategy Advisers first reported a position in NVRO in Q4 2015 and held it in 12 quarters. The position peaked at $4.09M in Q3 2017. 162 funds tracked by Wall St. Rank hold NVRO as of Q2 2019.

Weiss Multi-Strategy Advisers reported no remaining NEVRO CORP. position as of Q2 2019 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 15,000 NEVRO CORP. shares in Q2 2019, an estimated $938K.
Weiss Multi-Strategy Advisers first reported a position in NEVRO CORP. in Q4 2015 and held it in 12 quarters.
Weiss Multi-Strategy Advisers's NEVRO CORP. position peaked at $4.09M in Q3 2017.
162 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2019.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.